|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:Fosun_International
|
|
gptkbp:acquisition
|
gptkb:Gland_Pharma
|
|
gptkbp:awards
|
Top 100 Pharmaceutical Companies in China
Best Employer in China
|
|
gptkbp:capital
|
approximately $10 billion
|
|
gptkbp:ceo
|
gptkb:Liang_Xinjun
|
|
gptkbp:clinical_trial
|
ongoing
patient safety
international standards
efficacy studies
|
|
gptkbp:collaborations
|
academic institutions
research organizations
|
|
gptkbp:employees
|
over 10,000
|
|
gptkbp:financial_performance
|
strong market position
growing revenue
increasing profits
|
|
gptkbp:focus
|
distribution
research and development
manufacturing
|
|
gptkbp:founded
|
gptkb:1994
|
|
gptkbp:founder
|
gptkb:Guo_Guangchang
|
|
gptkbp:global_presence
|
gptkb:Africa
gptkb:Europe
gptkb:Asia
gptkb:Latin_America
gptkb:North_America
|
|
gptkbp:headquarters
|
gptkb:Shanghai,_China
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Fosun Pharma
|
|
gptkbp:industry
|
gptkb:drug
|
|
gptkbp:investment
|
gptkb:hospital
gptkb:Company
healthcare
|
|
gptkbp:language_of_instruction
|
oncology drugs
cardiovascular drugs
autoimmune drugs
|
|
gptkbp:parent_company
|
gptkb:Fosun_International_Limited
|
|
gptkbp:partnership
|
gptkb:Merck_&_Co.
Bio N Tech
|
|
gptkbp:partnerships
|
hospitals
healthcare providers
|
|
gptkbp:products
|
vaccines
therapeutics
diagnostics
|
|
gptkbp:regulatory_compliance
|
multiple countries
|
|
gptkbp:research_areas
|
gptkb:Europe
gptkb:China
gptkb:United_States
|
|
gptkbp:revenue
|
approximately $3 billion
|
|
gptkbp:social_responsibility
|
gptkb:healthcare_access
community health initiatives
sustainability efforts
|
|
gptkbp:stock_exchange
|
gptkb:Hong_Kong_Stock_Exchange
|
|
gptkbp:subsidiary
|
gptkb:Fosun_Kite_Biotechnology
gptkb:Fosun_Pharma_USA
|
|
gptkbp:supply_chain
|
regulatory compliance
quality control
global logistics
|
|
gptkbp:website
|
www.fosunpharma.com
|